Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC 9-Ing-41 (Elraglusib) | 1034895-42-5 | 404.35 | 10 MG
Supplier: Medchemexpress LLC HY11391410MG
9-ING-41 (Elraglusib) is a maleimide-based ATP-competitive and selective glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 of 0.71 μM. This compound leads to significant cell cycle arrest, autophagy, and apoptosis in cancer cells. It demonstrates anticancer activity and has potential for enhancing the antitumor effects of chemotherapeutic agents.
- Maleimide-based ATP-competitive and selective glycogen synthase kinase-3β (GSK-3β) inhibitor
- IC50 of 0.71 μM against GSK-3β
- Significantly induces cell cycle arrest in cancer cells
- Promotes autophagy in cancer cells
- Leads to apoptosis in cancer cells
- Exhibits anticancer activity
- Potential to enhance antitumor effects of chemotherapeutic agents
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?